What is the Astrana Health Inc. stock price forecast?

Astrana Health Inc. is currently trading at $38.62. View real-time AI analysis on Alpha Lenz.

What is Astrana Health Inc. insider trading activity?

View the latest insider trading data for Astrana Health Inc. on Alpha Lenz.

What is Astrana Health Inc.'s P/E ratio?

Astrana Health Inc.'s P/E ratio is 84.3.

Astrana Health Inc.

NASDAQ · ASTH

$38.62-1.23(-3.09%)Pre-market

Ask about Astrana Health Inc.'s future dividend policy...

Alpha Chat Insight

“Astrana Health Inc. trades at a P/E of 84.3 (premium valuation) with modest ROE of 3.0%. 3Y revenue CAGR of 40.6% highlights clear growth momentum.”

Ask for details →

Company Overview

Astrana Health Inc. is a healthcare company dedicated to providing innovative medical solutions and services. The primary focus of Astrana Health is on developing and delivering advanced therapeutics and health management services that address critical medical needs. The company operates within a framework that includes pharmaceuticals, biotechnology, and health services, impacting sectors such as oncology, cardiology, and chronic disease management. By leveraging cutting-edge research and development, Astrana Health aims to enhance patient outcomes and quality of life. Headquartered in a major metropolitan area, the company collaborates with healthcare providers, academic institutions, and government agencies to expand its reach and efficacy. Astrana Health Inc.'s role in the financial market is significant as it drives health innovation forward, responding to the growing global demand for effective healthcare treatments and solutions.

CEOMr. Brandon K. Sim M.S.

Websitehttps://www.astranahealth.com

SectorHealthcare

IndustryMedical Care Facilities

Employees1,900

Company Statistics

FY 2025

Profile

$1.90BMarket Cap

$3.18BRevenue

0.00Shares Out

1,900Employees

Margins

10.73%Gross

4.25%EBITDA

2.47%Operating

1.24%Pre-Tax

0.76%Net

Valuation

84.28P/E

2.43P/B

0.60EV/Sales

17.16EV/EBITDA

18.14P/FCF

Growth (CAGR)

40.62%Rev 3Yr

53.76%Rev 5Yr

-9.02%Op Inc 3Yr

66.78%Op Inc 5Yr

-19.26%Net Inc 3Yr

N/ANet Inc 5Yr

Returns

1.35%ROA

3.01%ROE

5.01%ROIC

Financial Health

$429.47MCash & Cash Equivalents

$1.23BNet Debt

297.37%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Astrana Health Inc. trades at a P/E of 84.3 (premium valuation) with modest ROE of 3.0%. 3Y revenue CAGR of 40.6% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Astrana Health Inc. (ticker: ASTH) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 1,900 employees. Market cap is $1.9B.

The current price is $38.62 with a P/E ratio of 84.28x and P/B of 2.43x.

ROE is 3.01% and operating margin is 2.47%. Annual revenue is $3.2B.